A synthetic leucine zipper-based dimerization system for combining multiple promoter specificities
- 1 May 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (9) , 725-729
- https://doi.org/10.1038/sj.gt.3301443
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 22 references indexed in Scilit:
- Tissue-Specific, Cell Cycle-Regulated Chimeric Transcription Factors for the Targeting of Gene Expression to Tumor CellsHuman Gene Therapy, 1998
- Construction, purification, and characterization of a hybrid protein comprising the DNA binding domain of the LexA repressor and the Jun leucine zipper: a circular dichroism and mutagenesis studyBiochemistry, 1991
- Non-leucine residues in the leucine repeats of Fos and Jun contribute to the stability and determine the specificity of dimerizationNucleic Acids Research, 1991
- Secondary structure of a leucine zipper determined by nuclear magnetic resonance spectroscopyBiochemistry, 1990
- Dimers, leucine zippers and DNA-binding domainsTrends in Genetics, 1990
- A Fos protein containing the Jun leucine zipper forms a homodimer which binds to the AP1 binding siteNature, 1989
- Preferential Heterodimer Formation by Isolated Leucine Zippers from Fos and JunScience, 1989
- Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA bindingNature, 1989
- The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformationCell, 1989
- The role of the leucine zipper in the fos–jun interactionNature, 1988